Functional Endoscopic Sinus Surgery Study

Launched by UNIVERSITY OF FLORIDA · May 29, 2019

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help reduce bleeding during a specific type of surgery called functional endoscopic sinus surgery (FESS), which is often performed on patients with chronic rhinosinusitis. The researchers want to see if adding a medication called epinephrine to a nerve block procedure can help control bleeding during surgery. This study is currently recruiting participants who are between the ages of 18 and 90, are scheduled for bilateral FESS, and do not have certain health conditions that could complicate the procedure.

If you or a family member are considering participation, you should know that you will be asked to consent to join the study, and your overall health will be evaluated to ensure you meet the criteria. Participants can expect to undergo the surgery as planned, with the added focus on monitoring how well the combination of epinephrine and nerve blocks works to minimize blood loss. It’s important to note that people with certain medical conditions or those who are not eligible based on the study's criteria will not be able to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patient presenting for bilateral FESS
• • 2. Adult patients (\>18 and \< 90 years old)
• • 3. Patient consents to participate
• • 4. No underlying chronic pain condition
• • 5. No underlying bleeding diathesis
• Exclusion Criteria:
• • 1. Patient refuses to consent
• • 2. Patient requires revision or unilateral surgery
• • 3. Patient requires surgery in addition to FESS
• • 4. Age younger than 18 or older than 90 years
• • 5. Any underlying chronic pain condition
• • 6. History of bleeding diathesis
• • 7. Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for block placement.
• • 8. Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for research participation.
• • 9. Vulnerable patient population